COOPER SURGICAL CONCLUSION
    

AT THE FOREFRONT OF WOMEN'S HEALTHCARE

By acquiring products, companies and technologies focused in gynecology, oncology and reproductive medicine, CSI has become a premier supplier of branded medical devices to the Ob/Gyn and has built the volume necessary to develop the first comprehensive medical device distribution system in women's healthcare. CSI has the profitability and market presence necessary for sustained growth and leadership within this very attractive segment.









SOURCES:

  • Physician's Drug and Diagnostic Audit, January – December 1999. Philadelphia, Pa: Scott-Levin, Inc.

  • Women's Health 2000, A Contemporary Ob/Gyn Fact Book. Contemporary Ob/Gyn 2000.

  • 1999 Technology Study. Contemporary Ob/Gyn,1999.

  • National Hospital Discharge Survey, Annual Summary, 1996. National Center for Health Statistics. Vital Health Statistics, 1998.

  • ACOG Economic Impact Study: Profile of Ob/Gyn Practices, 1991-1994: Washington,: American College of Obstetrics and Gynecology, 1996.

  • American Medical International Database, Los Angeles, CA, October 2000.

  • Women's Health 2000, A Contemporary Ob/Gyn Fact Book. Contemporary Ob/Gyn 2000.

  • Visscher CH, ed. Précis V, An Update in Obstetrics and Gynecology, American College of Obstetrics and Gynecology, 1994.

  • Novak's Gynecology, 12th Edition. Baltimore: Williams & Wilkins, 1996.

  • Holzman, GB, ed. Precis, Reproductive Endocrinology: An Update in Obstetrics and Gynecology. Washington, ACOG, 1998.